Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Krakow
Clinical trial register · Poland

Clinical Trials in Krakow, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2716 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2716
Studies in scope
all four open statuses
1383
Recruiting now
open to new participants
510
Lead sponsors
across recruiting studies
Top sites
Warsaw 23 Krakow 21 Lodz 20 Wroclaw 18 Poznan 15

Trials with a site in Krakow

21 of 2716 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Sanofi
Phase 3
751
Bydgoszcz, Elblag, Katowice, Krakow, Kłodzko, Lublin, Opole, Poznan
2026-01-16
Recruiting
Sanofi
Phase 3
980
Elblag, Katowice, Krakow, Lodz, Poznan, Rzeszów, Sopot, Staszów
2025-10-08
Recruiting
Sanofi
Phase 3
980
Bydgoszcz, Elblag, Katowice, Krakow, Kłodzko, Lodz, Lublin, Nowy Targ
2025-10-01
Recruiting
Sanofi
Phase 3
124
Krakow, Wroclaw, Gdansk
2025-09-26
Recruiting
Sanofi
Phase 3
942
Poznan, Krakow, Lodz, Bialystok, Chęciny, Ostrowiec Świętokrzyski
2025-09-17
Recruiting
Sanofi
Phase 2
99
Wroclaw, Krakow, Lublin, Sopot, Warsaw
2025-06-03
Active, closed
Sanofi
Phase 3
1,092
Bydgoszcz, Torun, Krakow, Trzebnica, Wroclaw, Warsaw, Łomianki, Siemianowice Śląskie
2025-05-22
Active, closed
Sanofi
Phase 2
71
Poznan, Krakow, Wroclaw, Warsaw, Katowice
2025-05-12
Active, closed
Sanofi
Phase 3
231
Krakow, Wroclaw, Lublin, Warsaw, Bialystok
2025-02-12
Active, closed
Sanofi
Phase 2
229
Poznan, Krakow, Wroclaw, Warsaw
2024-08-29
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Krakow, Lublin, Rzeszów
2024-07-12
Active, closed
Sanofi
Phase 2
185
Warsaw, Krakow
2024-06-20
Active, closed
Sanofi
Phase 3
943
Poznan, Bydgoszcz, Krakow, Rzeszów, Bialystok, Katowice, Zabrze
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Plewiska, Bydgoszcz, Krakow, Lublin, Lodz, Warsaw, Rzeszów, Katowice
2023-12-13
Active, closed
Sanofi
Phase 2
187
Włocławek, Wroclaw, Łęczna, Warsaw, Gdynia, Katowice, Tychy, Krakow
2022-11-25
Active, closed
Sanofi
Phase 2/3
1,856
Torun, Krakow, Tarnów, Wroclaw, Lublin, Lodz, Warsaw, Rzeszów
2022-08-22
Active, closed
Sanofi
Phase 3
531
Krakow, Wroclaw, Lublin
2022-06-23
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-poland/city/krakow

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,716 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Krakow that also match the filters currently applied.

How many clinical trials are recruiting in Krakow?

7 of the 21 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Krakow), 21 studies
PhaseStudiesRecruitingShare
Phase 315671.4%
Phase 25123.8%
Phase 2/3104.8%

Most active sponsors

Lead sponsors with the most studies (Krakow)
Lead sponsorStudiesRecruiting
Sanofi217
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.